Browsing Tag

Formulation/Drug Product Manufacturing

318 posts

Cambrex Completes Acquisition of Halo Pharma
By

By
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has completed its acquisition of Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization, for approximately $425 million.…

Avara Acquires Sterile Mfg. Facility from Sandoz
By

By
Avara Pharmaceutical Services, a Norwalk, Connecticut-headquartered contract development and manufacturing organization, has acquired Sandoz’s sterile manufacturing facility for injectable medicines in Canada, as part of a continuing expansion of its…

CDMO Ajinomoto Althea Opens New High Potency and Fill/Finish Facility
By

By
Ajinomoto Althea, a San Diego, California-headquartered contract development and manufacturing organization, has opened a new antibody drug conjugate and highly potent fill/finish facility near its existing campus in San Diego. …

Sterigenics To Build Gamma Sterilization Facility in UK
By

By
Sterigenics, a provider of contract sterilization, gamma technologies and medical isotopes, is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The new 60,000-square-foot facility will include the…

Cambrex To Acquire Halo Pharma for $425 Million
By

By
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has agreed to acquire Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization (CDMO),…

Amphstar To Expand Scope of Subsidiary for External Mfg
By

By
Amphastar Pharmaceuticals, a Rancho Cucamonga, California-based specialty pharmaceutical company, has announced plans to expand the scope of its subsidiary, Amphastar Nanjing Pharmaceuticals (ANP).   Amphastar is a specialty pharmaceutical company…

Evonik To Expand CDMO Facilities for Injectables
By

By
Evonik has announced plans to invest EUR 35 million ($41 million) to expand its contract development and manufacturing (CDMO) capabilities in North America for controlled-release injectable formulations. The expansion of…

Boehringer Ingelheim Completes New Fill/Finish Line in China
By

By
Boehringer Ingelheim (BI) has completed a new filling line at its commercial manufacturing facility in Shanghai, China for its contract manufacturing business, BioXcellence. The new isolator-based fill/finish line is for…

Catalent To Acquire Juniper Pharmaceuticals in $133-Million Deal
By

By
Catalent has agreed to acquire Juniper Pharmaceuticals, a Boston, Massachusetts-headquartered specialty pharmaceutical company with contract development and manufacturing services, including its Nottingham, UK-based Juniper Pharma Services Division, in a deal…

AMRI Signs NIH Contract for API and Drug-Product Mfg
By

By
AMRI, a contract research, development, and manufacturing organization, has signed a seven-year contract with the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health…